{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01298141",
      "orgStudyIdInfo": {
        "id": "HGT-REP-081"
      },
      "organization": {
        "fullName": "Takeda",
        "class": "INDUSTRY"
      },
      "briefTitle": "A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry Disease",
      "officialTitle": "A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal® (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry Disease"
    },
    "statusModule": {
      "statusVerifiedDate": "2021-05",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2011-08-10",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2017-09-25",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2017-09-25",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2011-02-15",
      "studyFirstSubmitQcDate": "2011-02-16",
      "studyFirstPostDateStruct": {
        "date": "2011-02-17",
        "type": "ESTIMATED"
      },
      "resultsFirstSubmitDate": "2018-09-24",
      "resultsFirstSubmitQcDate": "2018-09-24",
      "resultsFirstPostDateStruct": {
        "date": "2019-02-15",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2021-05-19",
      "lastUpdatePostDateStruct": {
        "date": "2021-06-08",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Shire",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "The purpose of this study is to observe the safety of agalsidase alfa in Canadian patients with Fabry disease.",
      "detailedDescription": "This study will evaluate the safety of agalsidase alfa in patients with Fabry disease.\n\nPatients diagnosed with Fabry disease who meet current Canadian guidelines for enzyme replacement therapy will be eligible to enroll in the study and will receive agalsidase alfa at a dose of 0.2 mg/kg body weight administered by an IV infusion over 40 minutes every week or every other week, based on previous treatment.\n\nShire has implemented a change to the drug substance manufacturing process. Safety data will be collected in patients receiving product manufactured with this process. There are no changes to the drug product formulation, manufacturing site, manufacturing process, and container closure."
    },
    "conditionsModule": {
      "conditions": [
        "Fabry Disease"
      ],
      "keywords": [
        "Replagal",
        "Enzyme Replacement Therapy",
        "agalsidase alfa"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "NA",
        "interventionModel": "SINGLE_GROUP",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 171,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Replagal®",
          "type": "EXPERIMENTAL",
          "description": "All eligible patients may receive Replagal produced by the bioreactor process (AF Replagal) on this treatment plan until AF Replagal is commercially available for the patient, the patient's participation is discontinued, or the study is discontinued, whichever comes first.",
          "interventionNames": [
            "Biological: agalsidase alfa"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "agalsidase alfa",
          "description": "Cohort 1: 0.2 mg/kg body weight administered as an intravenous (IV) infusion over 40 minutes every other week (EOW)\n\nCohort 2: 0.2 mg/kg body weight administered as an intravenous (IV) infusion over 40 minutes weekly",
          "armGroupLabels": [
            "Replagal®"
          ],
          "otherNames": [
            "Replagal"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Number of Participants With Treatment-emergent Adverse Events (TEAEs)",
          "description": "An adverse event (AE) was any noxious, pathologic, or unintended change in anatomical, physiologic, or metabolic function as indicated by physical signs, symptoms, or laboratory changes occurring in any phase of a clinical study, whether or not considered investigational product-related.Treatment-emergent adverse events (TEAEs) were defined as those events which occurred or worsened in severity after first treatment with Replagal AF until 30 days after the last dose. A serious AE (SAE) was any AE occurred at any dose that resulted in death, life-threatening, hospitalization, prolongation of existing hospitalization, persistent or significant disability or incapacity and congenital anomaly or birth defect.",
          "timeFrame": "From the start of study treatment up to 30 days after the last dose of study drug administration (up to 320 weeks)"
        },
        {
          "measure": "Number of Participants With Infusion-Related Reactions (IRR)",
          "description": "An IRR (also referred to as infusion-related adverse event \\[IRAE\\]) was defined as an AE that began either during the infusion or within 12 hours after the start of the infusion and was judged as possibly or probably related to study drug. The IRRs were classified based on the severity as Mild=No limitation of usual activities, Moderate=Some limitation of usual activities, Severe=Inability to carry out usual activities and Life-threatening=Immediate risk of death. The number of participants with infusion-related reactions was reported.",
          "timeFrame": "From the start of study treatment up to 30 days after the last dose of study drug administration (up to 320 weeks)"
        },
        {
          "measure": "Number of Participants Who Reported Positive to Immunoglobulin A (IgA)",
          "description": "The IgA status was measured using enzyme-linked immunosorbent assay (ELISA). Number of participants who reported positive to IgA was reported.",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 129"
        },
        {
          "measure": "Number of Participants Who Reported Positive to Immunoglobulin E (IgE)",
          "description": "The IgE status was measured using ELISA. Number of participants who reported positive to IgE was reported.",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 129"
        },
        {
          "measure": "Number of Participants Who Reported Positive to Immunoglobulin M (IgM)",
          "description": "The IgM status was measured using ELISA. Number of participants who reported positive to IgM was reported.",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 129"
        },
        {
          "measure": "Number of Participants Who Reported Positive to Anti-drug Antibody (ADA)",
          "description": "The ADA status was measured using ELISA and electrochemiluminescent (ECL) immunoassay. Number of participants who reported positive to ADA was reported.",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 285"
        },
        {
          "measure": "Number of Participants Who Reported Positive to Neutralizing Antibody (NAb)",
          "description": "The NAb status was measured using enzyme activity inhibition assay. Number of participants who reported positive to NAb was reported.",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 285"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\nCohort 1:\n\n1. The patient has a documented diagnosis of Fabry disease.\n2. The patient is sufficiently compliant with study activities to participate in this treatment plan, as judged by the Investigator.\n3. The patient must meet current Canadian guidelines for enzyme replacement therapy for Fabry disease by meeting one of the following criteria:\n\n   1. Age-adjusted glomerular filtration rate (GFR) \\<80 ml/min or a decline in GFR of \\>10% which is sustained for 3 months and for which other causes of declining renal function have been excluded by a nephrologist or any 2 of the following:\n\n      * Isolated proteinuria ≥500 mg/day/1.73 m2 without other cause\n      * Nephrogenic diabetes insipidus\n      * Fanconi syndrome\n      * Hypertension\n   2. Evidence of cardiac involvement related to Fabry disease including any 2 of the following:\n\n      * Left ventricular (LV) wall thickness \\>12 mm\n      * Left ventricular hypertrophy (LVH) by electrocardiogram (ECG); Estes ECG score must be \\>5\n      * Left ventricular mass index (LVMI) by 2D echocardiogram 20% above normal for age\n      * Diastolic filling abnormalities by 2D echocardiogram or by other accepted measures of diastolic filling. E/A ration \\>2.0 and deceleration time \\<140 msec\n      * Increase of LV mass of at least 5 g/m2/year, with three measurements over a minimum of 12 months\n      * Increase of left atrium (LA) size on 2D echo at least 10% above normal for age. In parasternal long axis view (PLAX) \\>33 mm; in four chamber view \\>42 mm\n      * Cardiac conduction and rhythm abnormalities: atrioventricular (AV) block, short PR interval, left branch bundle block (LBBB), ventricular or atrial tachyarrhythmias, sinus bradycardia (in the absence of drugs with negative chronotropic activity)\n      * Delayed posterolateral left ventricular wall late enhancement on MRI as evidence of advanced cardiac disease with fibrosis\n   3. Evidence of neurological involvement related to Fabry disease including 1 of the following:\n\n      * Stroke or transient ischemic attack (TIA) prior to the age of 55 documented by a neurologist\n      * Acute onset unilateral hearing loss\n      * Acut monocular visual loss without other cause\n   4. Chronic, intractable diarrhea and/or abdominal pain/cramps, refractory to standard management for at least 6 months.\n   5. Chronic, intractable neuropathic pain, refractory to analgesics and standard pain management for at least 6 months.\n\n   Cohort 2:\n4. Patient must have participated in Study REP001a.\n\nExclusion Criteria:\n\n1. The patient has experienced an anaphylactic or anaphylactoid reaction or other infusion-related reaction which, in the opinion of the Investigator, precludes further treatment with agalsidase alfa or may interfere with the interpretation of the study.\n2. The patient is otherwise unsuitable for the study, in the opinion of the Investigator.\n3. The patient is enrolled in another clinical study, other than the Canadian Fabry Disease Initiative (CFDI).",
      "healthyVolunteers": false,
      "sex": "ALL",
      "stdAges": [
        "CHILD",
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Study Director",
          "affiliation": "Takeda",
          "role": "STUDY_DIRECTOR"
        }
      ],
      "locations": [
        {
          "facility": "Alberta Children's Hospital",
          "city": "Calgary",
          "state": "Alberta",
          "zip": "T3B 6A8",
          "country": "Canada",
          "geoPoint": {
            "lat": 51.05011,
            "lon": -114.08529
          }
        },
        {
          "facility": "University of Alberta Hospital",
          "city": "Edmonton",
          "state": "Alberta",
          "zip": "T6G 2H7",
          "country": "Canada",
          "geoPoint": {
            "lat": 53.55014,
            "lon": -113.46871
          }
        },
        {
          "facility": "Vancouver General Hospital",
          "city": "Vancouver",
          "state": "British Columbia",
          "zip": "V5Z 1M9",
          "country": "Canada",
          "geoPoint": {
            "lat": 49.24966,
            "lon": -123.11934
          }
        },
        {
          "facility": "University of Manitoba",
          "city": "Winnipeg",
          "state": "Manitoba",
          "zip": "R3A 1S1",
          "country": "Canada",
          "geoPoint": {
            "lat": 49.8844,
            "lon": -97.14704
          }
        },
        {
          "facility": "Queen Elizabeth II Health Sciences Centre",
          "city": "Halifax",
          "state": "Nova Scotia",
          "zip": "B3H 1V8",
          "country": "Canada",
          "geoPoint": {
            "lat": 44.64269,
            "lon": -63.57688
          }
        },
        {
          "facility": "Izaak Walton Killam (IWK) Health Centre",
          "city": "Halifax",
          "state": "Nova Scotia",
          "zip": "B3K 6R8",
          "country": "Canada",
          "geoPoint": {
            "lat": 44.64269,
            "lon": -63.57688
          }
        },
        {
          "facility": "Kingston General Hospital",
          "city": "Kingston",
          "state": "Ontario",
          "zip": "K7L 3J6",
          "country": "Canada",
          "geoPoint": {
            "lat": 44.22976,
            "lon": -76.48098
          }
        },
        {
          "facility": "London Health Sciences Centre - Victoria Hospital",
          "city": "London",
          "state": "Ontario",
          "zip": "N6C 2V5",
          "country": "Canada",
          "geoPoint": {
            "lat": 42.98339,
            "lon": -81.23304
          }
        },
        {
          "facility": "The Hospital for Sick Children",
          "city": "Toronto",
          "state": "Ontario",
          "zip": "M5G 1X8",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.70643,
            "lon": -79.39864
          }
        },
        {
          "facility": "The Fred A. Litwin Family Centre in Genetic Medicine",
          "city": "Toronto",
          "state": "Ontario",
          "zip": "M5T 3L9",
          "country": "Canada",
          "geoPoint": {
            "lat": 43.70643,
            "lon": -79.39864
          }
        },
        {
          "facility": "Hopital du Sacre-Coeur de Montreal",
          "city": "Montreal",
          "state": "Quebec",
          "zip": "H4J 1C5",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.50884,
            "lon": -73.58781
          }
        },
        {
          "facility": "Centre Hospitalier Universitaire de Sherbrooke (CHUS)",
          "city": "Sherbrooke",
          "state": "Quebec",
          "zip": "J1H 5N4",
          "country": "Canada",
          "geoPoint": {
            "lat": 45.40008,
            "lon": -71.89908
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "34542871",
          "type": "DERIVED",
          "citation": "Khan A, Sirrs SM, Bichet DG, Morel CF, Tocoian A, Lan L, West ML; Canadian Fabry Disease Initiative. The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process. Drugs R D. 2021 Dec;21(4):385-397. doi: 10.1007/s40268-021-00361-4. Epub 2021 Sep 20."
        }
      ]
    }
  },
  "resultsSection": {
    "participantFlowModule": {
      "preAssignmentDetails": "A total of 171 participants enrolled into cohort 1 (participants from Canadian Fabry Disease Initiative \\[CFDI\\]) and cohort 2 (participants who participated in study REP001a) and among them 167 participants received at least one full or partial dose of Replagal (agalsidase alfa) animal free (AF).",
      "recruitmentDetails": "This multicenter study was conducted at 12 sites in Canada between 10 Aug 2011 (first participant first visit) and 25 Sep 2017 (last participant last visit).",
      "groups": [
        {
          "id": "FG000",
          "title": "Replagal (Agalsidase Alfa)",
          "description": "Participants in cohort 1 received Replagal AF intravenous (IV) infusion at a dose of 0.2 milligram per kilogram (mg/kg) body weight every other week (EOW) and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
        }
      ],
      "periods": [
        {
          "title": "Overall Study",
          "milestones": [
            {
              "type": "STARTED",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "171"
                }
              ]
            },
            {
              "type": "Treated",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "167"
                }
              ]
            },
            {
              "type": "COMPLETED",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "140"
                }
              ]
            },
            {
              "type": "NOT COMPLETED",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "31"
                }
              ]
            }
          ],
          "dropWithdraws": [
            {
              "type": "Adverse Event",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "3"
                }
              ]
            },
            {
              "type": "Refusal of Required Study Procedures",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "1"
                }
              ]
            },
            {
              "type": "Withdrawal by Subject",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "6"
                }
              ]
            },
            {
              "type": "Termination of Study by the Investigator",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "5"
                }
              ]
            },
            {
              "type": "Other",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "5"
                }
              ]
            },
            {
              "type": "Lost to Follow-up",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "1"
                }
              ]
            },
            {
              "type": "Death",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "6"
                }
              ]
            },
            {
              "type": "Not treated",
              "reasons": [
                {
                  "groupId": "FG000",
                  "numSubjects": "4"
                }
              ]
            }
          ]
        }
      ]
    },
    "baselineCharacteristicsModule": {
      "populationDescription": "Safety Population included all participants who received at least one full or partial infusion of Replagal AF.",
      "groups": [
        {
          "id": "BG000",
          "title": "Replagal (Agalsidase Alfa)",
          "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
        }
      ],
      "denoms": [
        {
          "units": "Participants",
          "counts": [
            {
              "groupId": "BG000",
              "value": "167"
            }
          ]
        }
      ],
      "measures": [
        {
          "title": "Age, Continuous",
          "description": "Age at Informed Consent",
          "paramType": "MEAN",
          "dispersionType": "STANDARD_DEVIATION",
          "unitOfMeasure": "Years",
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "48.85",
                      "spread": "14.821"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Sex: Female, Male",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "categories": [
                {
                  "title": "Female",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "76"
                    }
                  ]
                },
                {
                  "title": "Male",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "91"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Ethnicity (NIH/OMB)",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "categories": [
                {
                  "title": "Hispanic or Latino",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "2"
                    }
                  ]
                },
                {
                  "title": "Not Hispanic or Latino",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "165"
                    }
                  ]
                },
                {
                  "title": "Unknown or Not Reported",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "0"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Race (NIH/OMB)",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "categories": [
                {
                  "title": "American Indian or Alaska Native",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "0"
                    }
                  ]
                },
                {
                  "title": "Asian",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "5"
                    }
                  ]
                },
                {
                  "title": "Native Hawaiian or Other Pacific Islander",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "0"
                    }
                  ]
                },
                {
                  "title": "Black or African American",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "0"
                    }
                  ]
                },
                {
                  "title": "White",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "160"
                    }
                  ]
                },
                {
                  "title": "More than one race",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "0"
                    }
                  ]
                },
                {
                  "title": "Unknown or Not Reported",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "2"
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    "outcomeMeasuresModule": {
      "outcomeMeasures": [
        {
          "type": "PRIMARY",
          "title": "Number of Participants With Treatment-emergent Adverse Events (TEAEs)",
          "description": "An adverse event (AE) was any noxious, pathologic, or unintended change in anatomical, physiologic, or metabolic function as indicated by physical signs, symptoms, or laboratory changes occurring in any phase of a clinical study, whether or not considered investigational product-related.Treatment-emergent adverse events (TEAEs) were defined as those events which occurred or worsened in severity after first treatment with Replagal AF until 30 days after the last dose. A serious AE (SAE) was any AE occurred at any dose that resulted in death, life-threatening, hospitalization, prolongation of existing hospitalization, persistent or significant disability or incapacity and congenital anomaly or birth defect.",
          "populationDescription": "Safety Population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "From the start of study treatment up to 30 days after the last dose of study drug administration (up to 320 weeks)",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "title": "Any TEAE",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "163"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Any Serious TEAE",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "74"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Any TEAE Leading to Treatment Discontinuation",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "7"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": "PRIMARY",
          "title": "Number of Participants With Infusion-Related Reactions (IRR)",
          "description": "An IRR (also referred to as infusion-related adverse event \\[IRAE\\]) was defined as an AE that began either during the infusion or within 12 hours after the start of the infusion and was judged as possibly or probably related to study drug. The IRRs were classified based on the severity as Mild=No limitation of usual activities, Moderate=Some limitation of usual activities, Severe=Inability to carry out usual activities and Life-threatening=Immediate risk of death. The number of participants with infusion-related reactions was reported.",
          "populationDescription": "Safety Population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "From the start of study treatment up to 30 days after the last dose of study drug administration (up to 320 weeks)",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "title": "Mild",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "21"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Moderate",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "16"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Severe",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "3"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Life-threatening",
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "0"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": "PRIMARY",
          "title": "Number of Participants Who Reported Positive to Immunoglobulin A (IgA)",
          "description": "The IgA status was measured using enzyme-linked immunosorbent assay (ELISA). Number of participants who reported positive to IgA was reported.",
          "populationDescription": "Safety population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 129",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "10"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": "PRIMARY",
          "title": "Number of Participants Who Reported Positive to Immunoglobulin E (IgE)",
          "description": "The IgE status was measured using ELISA. Number of participants who reported positive to IgE was reported.",
          "populationDescription": "Safety population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 129",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "1"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": "PRIMARY",
          "title": "Number of Participants Who Reported Positive to Immunoglobulin M (IgM)",
          "description": "The IgM status was measured using ELISA. Number of participants who reported positive to IgM was reported.",
          "populationDescription": "Safety population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 129",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "48"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": "PRIMARY",
          "title": "Number of Participants Who Reported Positive to Anti-drug Antibody (ADA)",
          "description": "The ADA status was measured using ELISA and electrochemiluminescent (ECL) immunoassay. Number of participants who reported positive to ADA was reported.",
          "populationDescription": "Safety population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 285",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "42"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": "PRIMARY",
          "title": "Number of Participants Who Reported Positive to Neutralizing Antibody (NAb)",
          "description": "The NAb status was measured using enzyme activity inhibition assay. Number of participants who reported positive to NAb was reported.",
          "populationDescription": "Safety population included all participants who received at least one full or partial infusion of Replagal AF.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "Baseline (within 6 months prior to first dose) up to Week 285",
          "groups": [
            {
              "id": "OG000",
              "title": "Replagal (Agalsidase Alfa)",
              "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first."
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "167"
                }
              ]
            }
          ],
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "27"
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    "adverseEventsModule": {
      "frequencyThreshold": "5",
      "timeFrame": "From the start of study treatment up to 30 days after the last dose of study drug administration (up to 320 weeks)",
      "eventGroups": [
        {
          "id": "EG000",
          "title": "Replagal (Agalsidase Alfa)",
          "description": "Participants in cohort 1 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight EOW and cohort 2 received Replagal AF IV infusion at a dose of 0.2 mg/kg body weight weekly until the drug became commercially available or the participant discontinued, whichever came first.",
          "deathsNumAffected": 6,
          "deathsNumAtRisk": 167,
          "seriousNumAffected": 74,
          "seriousNumAtRisk": 167,
          "otherNumAffected": 160,
          "otherNumAtRisk": 167
        }
      ],
      "seriousEvents": [
        {
          "term": "Anaemia",
          "organSystem": "Blood and lymphatic system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 5,
              "numAffected": 5,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Iron deficiency anaemia",
          "organSystem": "Blood and lymphatic system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pancytopenia",
          "organSystem": "Blood and lymphatic system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Thrombocytopenia",
          "organSystem": "Blood and lymphatic system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cervical spinal stenosis",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Osteolysis",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Osteonecrosis",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pain in extremity",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Splenic neoplasm malignancy unspecified",
          "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Thyroid cancer",
          "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Deep vein thrombosis",
          "organSystem": "Vascular disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Thrombophlebitis superficial",
          "organSystem": "Vascular disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypoacusis",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Sudden hearing loss",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Vertigo positional",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Vestibular disorder",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Eye swelling",
          "organSystem": "Eye disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Abdominal discomfort",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Abdominal pain",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Abdominal pain lower",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Colitis",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Constipation",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Diarrhoea",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dysphagia",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 3,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Gastric haemorrhage",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Gastrointestinal haemorrhage",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Gastrooesophageal reflux disease",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Haemorrhoidal haemorrhage",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypoaesthesia oral",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 4,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Inguinal hernia",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Intestinal perforation",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nausea",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pancreatitis",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Paraesthesia oral",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Retroperitoneal haematoma",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Swollen tongue",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Umbilical hernia",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Upper gastrointestinal haemorrhage",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Asthenia",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Chest pain",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Device malfunction",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Malaise",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Non-Cardiac chest pain",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Oedema peripheral",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pyrexia",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Fabry's disease",
          "organSystem": "Congenital, familial and genetic disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 3,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pyloric stenosis",
          "organSystem": "Congenital, familial and genetic disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Acute coronary syndrome",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 4,
              "numAffected": 4,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Acute myocardial infarction",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 3,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Angina pectoris",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 6,
              "numAffected": 6,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Angina unstable",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Aortic valve incompetence",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Aortic valve stenosis",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Atrial fibrillation",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 7,
              "numAffected": 5,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Atrial flutter",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac arrest",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac failure",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac failure congestive",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 4,
              "numAffected": 4,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Coronary artery disease",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Coronary artery stenosis",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypertrophic cardiomyopathy",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Intracardiac thrombus",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Left ventricular dysfunction",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Myocardial infarction",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 8,
              "numAffected": 7,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Palpitations",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Supraventricular tachycardia",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Ventricular tachycardia",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 7,
              "numAffected": 7,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Anaphylactic reaction",
          "organSystem": "Immune system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Kidney transplant rejection",
          "organSystem": "Immune system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Bacteraemia",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Bacterial sepsis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Beta haemolytic streptococcal infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cellulitis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 9,
              "numAffected": 7,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cholangitis suppurative",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cytomegalovirus viraemia",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Device related infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Escherichia bacteraemia",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Influenza",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Perihepatic abscess",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pneumonia",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 7,
              "numAffected": 7,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pneumonia adenoviral",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pneumonia cytomegaloviral",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pneumonia primary atypical",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pseudomonal sepsis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Sepsis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Septic shock",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Tooth abscess",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Upper respiratory tract infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Urosepsis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Accident",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Accidental overdose",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 4,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Ankle fracture",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Fall",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Foot fracture",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hip fracture",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Intentional overdose",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Psychosis postoperative",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Rib fracture",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Scapula fracture",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Soft tissue injury",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Ejection fraction decreased",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Electrocardiogram qt prolonged",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Enterococcus test positive",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Heart rate decreased",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Troponin increased",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Weight decreased",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nephrolithiasis",
          "organSystem": "Renal and urinary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nephropathy",
          "organSystem": "Renal and urinary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Renal failure",
          "organSystem": "Renal and urinary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Renal failure acute",
          "organSystem": "Renal and urinary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 8,
              "numAffected": 7,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Renal failure chronic",
          "organSystem": "Renal and urinary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 9,
              "numAffected": 8,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Biloma",
          "organSystem": "Hepatobiliary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cholangitis acute",
          "organSystem": "Hepatobiliary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cholecystitis",
          "organSystem": "Hepatobiliary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cholecystitis acute",
          "organSystem": "Hepatobiliary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cholelithiasis",
          "organSystem": "Hepatobiliary disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dehydration",
          "organSystem": "Metabolism and nutrition disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 3,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Failure to thrive",
          "organSystem": "Metabolism and nutrition disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hyperglycaemia",
          "organSystem": "Metabolism and nutrition disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Aphasia",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cerebral infarction",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cerebrovascular accident",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 8,
              "numAffected": 8,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypoaesthesia",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 5,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Ischaemic stroke",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nervous system disorder",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Neuralgia",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Presyncope",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Syncope",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 3,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Tension headache",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Transient ischaemic attack",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 4,
              "numAffected": 3,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Tremor",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Aortic valve replacement",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac ablation",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac pacemaker insertion",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac pacemaker replacement",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac pacemaker revision",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Implantable defibrillator insertion",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Implantable defibrillator replacement",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Mitral valve replacement",
          "organSystem": "Surgical and medical procedures",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Depression",
          "organSystem": "Psychiatric disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Endometrial hyperplasia",
          "organSystem": "Reproductive system and breast disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Priapism",
          "organSystem": "Reproductive system and breast disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Choking sensation",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cough",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 3,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dyspnoea",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 5,
              "numAffected": 2,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Increased upper airway secretion",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pneumothorax",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pulmonary embolism",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Respiratory tract congestion",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Tracheal stenosis",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Erythema",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypoaesthesia facial",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Piloerection",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pruritus generalised",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 167
            }
          ]
        }
      ],
      "otherEvents": [
        {
          "term": "Anaemia",
          "organSystem": "Blood and lymphatic system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 25,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Arthralgia",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 68,
              "numAffected": 45,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Back pain",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 63,
              "numAffected": 46,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Joint swelling",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 17,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Muscle spasms",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 30,
              "numAffected": 22,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Muscular weakness",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 12,
              "numAffected": 10,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Musculoskeletal pain",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 29,
              "numAffected": 23,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Myalgia",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 22,
              "numAffected": 21,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Neck pain",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 14,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Osteoarthritis",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 12,
              "numAffected": 12,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pain in extremity",
          "organSystem": "Musculoskeletal and connective tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 49,
              "numAffected": 34,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Flushing",
          "organSystem": "Vascular disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 49,
              "numAffected": 9,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypertension",
          "organSystem": "Vascular disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 22,
              "numAffected": 17,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypotension",
          "organSystem": "Vascular disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 23,
              "numAffected": 17,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Ear pain",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 11,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Tinnitus",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 17,
              "numAffected": 17,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Vertigo",
          "organSystem": "Ear and labyrinth disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 26,
              "numAffected": 23,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Vision blurred",
          "organSystem": "Eye disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 19,
              "numAffected": 16,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Abdominal discomfort",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 14,
              "numAffected": 13,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Abdominal pain",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 50,
              "numAffected": 29,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Abdominal pain upper",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 21,
              "numAffected": 17,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Constipation",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Diarrhoea",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 90,
              "numAffected": 51,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dyspepsia",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 12,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Gastrooesophageal reflux disease",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 12,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Haematochezia",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 9,
              "numAffected": 9,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nausea",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 119,
              "numAffected": 57,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Vomiting",
          "organSystem": "Gastrointestinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 79,
              "numAffected": 44,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Asthenia",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 18,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Chest discomfort",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Chest pain",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 22,
              "numAffected": 16,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Chills",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 30,
              "numAffected": 15,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Fatigue",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 95,
              "numAffected": 70,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Influenza like illness",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 21,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Non-Cardiac chest pain",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 27,
              "numAffected": 23,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Oedema",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 10,
              "numAffected": 9,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Oedema peripheral",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 82,
              "numAffected": 56,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pain",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 21,
              "numAffected": 16,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pyrexia",
          "organSystem": "General disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 35,
              "numAffected": 28,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Angina pectoris",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 44,
              "numAffected": 22,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Palpitations",
          "organSystem": "Cardiac disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 49,
              "numAffected": 35,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Bronchitis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 21,
              "numAffected": 18,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cellulitis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 15,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cystitis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 15,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Ear infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 14,
              "numAffected": 13,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Influenza",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 45,
              "numAffected": 31,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Localised infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 17,
              "numAffected": 12,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Lower respiratory tract infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 21,
              "numAffected": 19,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nasopharyngitis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 123,
              "numAffected": 64,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pneumonia",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 18,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Sinusitis",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 25,
              "numAffected": 17,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Upper respiratory tract infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 20,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Urinary tract infection",
          "organSystem": "Infections and infestations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 38,
              "numAffected": 23,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Contusion",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 29,
              "numAffected": 21,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Skin laceration",
          "organSystem": "Injury, poisoning and procedural complications",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 10,
              "numAffected": 9,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cardiac murmur",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 12,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Temperature difference of extremities",
          "organSystem": "Investigations",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 18,
              "numAffected": 16,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Gout",
          "organSystem": "Metabolism and nutrition disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 9,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Balance disorder",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 9,
              "numAffected": 9,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dizziness",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 85,
              "numAffected": 54,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Headache",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 104,
              "numAffected": 54,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hypoaesthesia",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 31,
              "numAffected": 26,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Migraine",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 13,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Neuralgia",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 63,
              "numAffected": 32,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Paraesthesia",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 31,
              "numAffected": 29,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Syncope",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 11,
              "numAffected": 10,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Tremor",
          "organSystem": "Nervous system disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 19,
              "numAffected": 17,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Anxiety",
          "organSystem": "Psychiatric disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 22,
              "numAffected": 19,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Depression",
          "organSystem": "Psychiatric disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 13,
              "numAffected": 12,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Insomnia",
          "organSystem": "Psychiatric disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 13,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Cough",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 82,
              "numAffected": 51,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dyspnoea",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 58,
              "numAffected": 40,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Dyspnoea exertional",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 16,
              "numAffected": 14,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Epistaxis",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 25,
              "numAffected": 16,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Nasal congestion",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 19,
              "numAffected": 16,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Oropharyngeal pain",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 34,
              "numAffected": 24,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Productive cough",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 17,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Respiratory tract congestion",
          "organSystem": "Respiratory, thoracic and mediastinal disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 11,
              "numAffected": 10,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Angiokeratoma",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 11,
              "numAffected": 11,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Hyperhidrosis",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 29,
              "numAffected": 19,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Pruritus",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 13,
              "numAffected": 10,
              "numAtRisk": 167
            }
          ]
        },
        {
          "term": "Rash",
          "organSystem": "Skin and subcutaneous tissue disorders",
          "sourceVocabulary": "MedDRA 13.1",
          "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 24,
              "numAffected": 18,
              "numAtRisk": 167
            }
          ]
        }
      ]
    },
    "moreInfoModule": {
      "certainAgreement": {
        "piSponsorEmployee": false,
        "restrictionType": "OTHER",
        "restrictiveAgreement": true,
        "otherDetails": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually."
      },
      "pointOfContact": {
        "title": "Study Director",
        "organization": "Shire",
        "email": "ClinicalTransparency@shire.com",
        "phone": "+1 866 842 5335"
      }
    }
  },
  "documentSection": {
    "largeDocumentModule": {
      "largeDocs": [
        {
          "typeAbbrev": "Prot",
          "hasProtocol": true,
          "hasSap": false,
          "hasIcf": false,
          "label": "Study Protocol: Original Protocol",
          "date": "2010-09-30",
          "uploadDate": "2018-09-21T06:55",
          "filename": "Prot_000.pdf",
          "size": 215422
        },
        {
          "typeAbbrev": "Prot",
          "hasProtocol": true,
          "hasSap": false,
          "hasIcf": false,
          "label": "Study Protocol: Amendment 1",
          "date": "2010-11-23",
          "uploadDate": "2018-09-21T06:59",
          "filename": "Prot_001.pdf",
          "size": 686561
        },
        {
          "typeAbbrev": "Prot",
          "hasProtocol": true,
          "hasSap": false,
          "hasIcf": false,
          "label": "Study Protocol: Amendment 2",
          "date": "2010-12-06",
          "uploadDate": "2018-09-21T07:00",
          "filename": "Prot_002.pdf",
          "size": 689515
        },
        {
          "typeAbbrev": "Prot",
          "hasProtocol": true,
          "hasSap": false,
          "hasIcf": false,
          "label": "Study Protocol: Amendment 3",
          "date": "2011-09-15",
          "uploadDate": "2018-09-21T07:00",
          "filename": "Prot_003.pdf",
          "size": 814820
        },
        {
          "typeAbbrev": "Prot",
          "hasProtocol": true,
          "hasSap": false,
          "hasIcf": false,
          "label": "Study Protocol: Amendment 4",
          "date": "2013-03-28",
          "uploadDate": "2018-09-21T07:01",
          "filename": "Prot_004.pdf",
          "size": 2060813
        },
        {
          "typeAbbrev": "Prot",
          "hasProtocol": true,
          "hasSap": false,
          "hasIcf": false,
          "label": "Study Protocol: Amendment 5",
          "date": "2015-03-27",
          "uploadDate": "2018-09-21T07:01",
          "filename": "Prot_005.pdf",
          "size": 2234825
        },
        {
          "typeAbbrev": "SAP",
          "hasProtocol": false,
          "hasSap": true,
          "hasIcf": false,
          "label": "Statistical Analysis Plan",
          "date": "2017-12-06",
          "uploadDate": "2018-09-21T07:02",
          "filename": "SAP_006.pdf",
          "size": 1953501
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D000795",
          "term": "Fabry Disease"
        }
      ],
      "ancestors": [
        {
          "id": "D013106",
          "term": "Sphingolipidoses"
        },
        {
          "id": "D020140",
          "term": "Lysosomal Storage Diseases, Nervous System"
        },
        {
          "id": "D020739",
          "term": "Brain Diseases, Metabolic, Inborn"
        },
        {
          "id": "D001928",
          "term": "Brain Diseases, Metabolic"
        },
        {
          "id": "D001927",
          "term": "Brain Diseases"
        },
        {
          "id": "D002493",
          "term": "Central Nervous System Diseases"
        },
        {
          "id": "D009422",
          "term": "Nervous System Diseases"
        },
        {
          "id": "D059345",
          "term": "Cerebral Small Vessel Diseases"
        },
        {
          "id": "D002561",
          "term": "Cerebrovascular Disorders"
        },
        {
          "id": "D014652",
          "term": "Vascular Diseases"
        },
        {
          "id": "D002318",
          "term": "Cardiovascular Diseases"
        },
        {
          "id": "D040181",
          "term": "Genetic Diseases, X-Linked"
        },
        {
          "id": "D030342",
          "term": "Genetic Diseases, Inborn"
        },
        {
          "id": "D009358",
          "term": "Congenital, Hereditary, and Neonatal Diseases and Abnormalities"
        },
        {
          "id": "D008661",
          "term": "Metabolism, Inborn Errors"
        },
        {
          "id": "D008064",
          "term": "Lipidoses"
        },
        {
          "id": "D008052",
          "term": "Lipid Metabolism, Inborn Errors"
        },
        {
          "id": "D016464",
          "term": "Lysosomal Storage Diseases"
        },
        {
          "id": "D008659",
          "term": "Metabolic Diseases"
        },
        {
          "id": "D009750",
          "term": "Nutritional and Metabolic Diseases"
        },
        {
          "id": "D052439",
          "term": "Lipid Metabolism Disorders"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "C000627036",
          "term": "agalsidase alfa"
        }
      ]
    }
  },
  "hasResults": true
}